WHO ICTRP trial

Comparison of the effects of remazolam and midazolam on the incidence of…

ChiCTR2000037704 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2000037704
Public title Comparison of the effects of remazolam and midazolam on the incidence of delirium following general anesthesia in patients undergoing elective non- cardiac major surgery: a prospective randomized controlled study
Scientific title Comparison of the effects of remazolam and midazolam on the incidence of delirium following general anesthesia in patients undergoing elective non- cardiac major surgery
Primary sponsor The Third Affiliated Hospital of Sun Yat-sen University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 0
Countries China
Conditions Delirium
Interventions Mida group:Midazolam is injected intravenously before surgery;Remi group :Remazolam is injected intravenously before surgery
Registration date Sep 2, 2020
Target size Mida group:40;Remi group :40
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations